Literature DB >> 11355270

MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.

B Birkedal-Hansen1, Z P Pavelic, J L Gluckman, P Stambrook, Y Q Li, W G Stetler-Stevenson.   

Abstract

OBJECTIVE: To compare the frequency of gene expression of matrix metalloproteinases (MMP) stromelysins -1, -2 and -3 (MMP-3, -10, and -11), matrilysin (MMP-7), MTI-MMP (MMP-14), and of TIMPs (Tissue Inhibitors of MMPs) -1, -2, -3 and -4 in head and neck squamous cell carcinomas with those of matched adjacent normal tissues.
MATERIALS AND METHODS: The present study included 20 surgically removed head and neck squamous cell carcinomas, seven of which were accompanied by matched adjacent oral mucosa excised from the border of the specimens outside the tumor area. RNA isolated from tumors and control samples was subjected to RT-PCR using primers specific for MMP-3, -7, -10, -11 and -14 and for TIMPs -1, -2, -3, and -4.
RESULTS: Our findings demonstrate that each of the five MMP genes studied were expressed in essentially all the tumors, while the adjacent marginal tissue samples showed a more varied picture: while stromelysin-3 was located to a majority of the marginal samples, matrilysin was expressed in four of seven adjacent samples, stromelysin-1 and MTI-MMP genes were each expressed in three of these samples, and stromelysin-2 transcript was only expressed in two marginal tissue samples. Whereas TIMP-1 and TIMP-2 transcripts were identified in all tumor and adjacent tissue samples studied, TIMP-3 was expressed, albeit often at low levels, in 17 of 20 tumor samples but only in three of seven adjacent tissues. The novel TIMP-4 gene was not expressed at all.
CONCLUSIONS: Specific MMP (MMP-3, -7, -10, -14) and TIMP-3 transcripts observed in head and neck squamous cell carcinomas compared to their frequency in specimens of matching tissues provide important information about expression of extracellular matrix degrading enzymes and their tissue inhibitors in head and neck carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11355270     DOI: 10.1111/j.1601-0825.2000.tb00130.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  8 in total

1.  Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.

Authors:  Zufei Li; Shuo Ding; Qi Zhong; Guojun Li; Yang Zhang; Xiaohong ChenZhigang Huang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.

Authors:  Erica L Johnson; Rajesh Singh; Shailesh Singh; Crystal M Johnson-Holiday; William E Grizzle; Edward E Partridge; James W Lillard
Journal:  World J Surg Oncol       Date:  2010-07-22       Impact factor: 2.754

3.  Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.

Authors:  Shailesh Singh; Rajesh Singh; Udai P Singh; Shesh N Rai; Kristian R Novakovic; Leland W K Chung; Peter J Didier; William E Grizzle; James W Lillard
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

4.  Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin.

Authors:  Monika Krampert; Wilhelm Bloch; Takako Sasaki; Philippe Bugnon; Thomas Rülicke; Eckhard Wolf; Monique Aumailley; William C Parks; Sabine Werner
Journal:  Mol Biol Cell       Date:  2004-09-15       Impact factor: 4.138

Review 5.  Matrix metalloproteases in head and neck cancer.

Authors:  Eben L Rosenthal; Lynn M Matrisian
Journal:  Head Neck       Date:  2006-07       Impact factor: 3.147

6.  Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin.

Authors:  Jeffrey M Schafer; Diane E Peters; Thomas Morley; Shihui Liu; Alfredo A Molinolo; Stephen H Leppla; Thomas H Bugge
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

7.  High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.

Authors:  Chung-Han Hsin; Mu-Kuan Chen; Chih-Hsin Tang; Huang-Pin Lin; Ming-Yung Chou; Chiao-Wen Lin; Shun-Fa Yang
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

8.  Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.

Authors:  Anxun Wang; Bin Zhang; Hongzhang Huang; Leitao Zhang; Donglin Zeng; Qian Tao; Jianguang Wang; Chaobin Pan
Journal:  BMC Cancer       Date:  2008-06-30       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.